Preveceutical Medical Inc C.PREV

Alternate Symbol(s): PRVCF

Healthcare Biotechnology

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).

CSE:PREV - Post by User

Preveceutical Medical Inc

Bullboard Posts

Post by dontherapyon Dec 01, 2018 5:57pm

70 Views

Post# 29050015

2018 bcsecom 369 temporary order notice of hearing

investigation date ..the issuer #64 prevecutical. 5 days ago hearing process 12th floor room 701 west Georgia street Friday dec.7th- 10am ...securities issued to member of bridgemark group...2018 june 80 million shares $4 million dollar illegal distribution of securities purporting to the consultants total scheme that Is the case ..good hunting

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal